Supplemental announcement in relation to the annual report for the year ended 31 December 2025
Filed with HKEX · Stock code 1763 · · 1 page · English
Summary by 6ix AI
This filing is a supplemental announcement related to the annual report for China Isotope & Radiation Corporation for a specific year. It provides additional information regarding related party transactions disclosed in the annual report, confirming compliance with relevant listing rules. The announcement states that all other information in the annual report remains unchanged.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
China Isotope & Radiation Corp. on 6ix
Earlier from China Isotope & Radiation
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Documents on Display
- Proxy form for the extraordinary general meeting
- Connected transaction and discloseable transaction proposed appointment of director proposed interim dividend and proposed grant of general mandate to issue shares
- Notice of extraordinary general meeting
Later from China Isotope & Radiation
- Voluntary announcement - zhonghe headway's 50mg Urea 13C breath test kit has obtained the drug registration certificate
- An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
- Poll results of extraordinary general meeting
- List of directors and their role and function
- (UPDATED) Interim Dividend for the Six Months Ended 30 June 2026
Follow China Isotope & Radiation into a list and get an email when it puts out news.
Follow China Isotope & Radiation